UMass Amherst researchers are developing technology to make extremely pure and plentiful RNA that could enable a new class of vaccines and treatments for a range of deadly diseases.
— Read on www.umass.edu/gateway/article/mrna-holds-key-next-gen-vaccines-and-therapeutics